Celerion Expands ADME Suite in Lincoln

Celerion has expanded its ADME (Absorption, Distribution, Metabolism and Excretion) suite in Lincoln, NE. The company invested in new equipment and lab space to perform on-site scintillation counting allowing for radioactivity recovery results to be delivered in real-time. This service aims to ensure high total recovery of radioactive dose while providing for efficient clinical study conduct.
 
“The enhancement in our facility was driven by client needs, including a growing interest in conducting these critical studies earlier in a drug’s development.  This is a response to regulatory guidances concerning knowledge of human metabolism and metabolites during safety assessment,” said Raymond Farmen, vice president, Global Bioanalytical Services. “The on-site bioanalytical and Phase I clinical facilities in Lincoln offer seamless integration of services and data. For bioanalytical analyses, the ADME suite interfaces with Celerion’s global electronic laboratory notebook system thereby increasing data compliance.”